Exacerbations of chronic obstructive pulmonary disease.
暂无分享,去创建一个
[1] J. M. Harris,et al. Acute infective exacerbations of chronic bronchitis. , 1995, QJM : monthly journal of the Association of Physicians.
[2] S. Yancey,et al. Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.
[3] P. Poole,et al. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review , 2001, BMJ : British Medical Journal.
[4] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[5] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[6] K. Nichol,et al. Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease , 1999, Annals of Internal Medicine.
[7] D. Niewoehner,et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.
[8] J. V. van Noord,et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.
[9] T. Seemungal,et al. Chlamydia pneumoniae and COPD exacerbation. , 2002, Thorax.
[10] J. Ruiz,et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. , 1999, The European respiratory journal.
[11] F. Blasi,et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment , 2002, Thorax.
[12] B. Meyboom-de Jong,et al. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. , 1995, Thorax.
[13] T. Seemungal,et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.
[14] W. Hop,et al. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.
[15] T. Seemungal,et al. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[16] R. Stockley,et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.
[17] J. Wedzicha,et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[18] E. Vittinghoff,et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.
[19] T. Seemungal,et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[20] R. Stockley,et al. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). , 1999, American journal of respiratory and critical care medicine.
[21] J. Pijoan,et al. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[22] J. Wedzicha,et al. An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. , 1999, Respiratory medicine.
[23] T. Seemungal,et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations , 2002, Thorax.
[24] P. Jones,et al. Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. , 1997, The European respiratory journal.
[25] J. Polu,et al. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. , 1994, Chest.
[26] T. Seemungal,et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[27] F. Hargreave,et al. Airway eosinophilia in chronic bronchitis during exacerbations. , 1996, American journal of respiratory and critical care medicine.
[28] S. Spencer,et al. Time course of recovery of health status following an infective exacerbation of chronic bronchitis , 2003, Thorax.
[29] P. Jones,et al. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. , 1996, Thorax.
[30] N. Anthonisen,et al. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.
[31] A. Adelman. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. , 1999, The Journal of family practice.
[32] H. Inskip,et al. Personal exposure to nitrogen dioxide and risk of airflow obstruction in asthmatic children with upper respiratory infection , 2000, Thorax.
[33] T. Seemungal,et al. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease , 1998, Thorax.
[34] B. Grant,et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.
[35] S. E. Jones,et al. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long term follow up and effect on survival , 1998, Thorax.
[36] J. Crowley,et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.
[37] C. Fletcher. The Natural history of chronic bronchitis and emphysema: An eight-year study of early chronic obstructive lung disease in working men in London , 1976 .
[38] A. Gillissen,et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study , 2003, Thorax.
[39] R. Stockley,et al. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. , 2000, The European respiratory journal.
[40] R. Stockley,et al. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. , 2001, American journal of respiratory and critical care medicine.
[41] RISK FACTORS OF READMISSION TO HOSPITAL FOR A COPD EXACERBATION: A PROSPECTIVE STUDY , 2003 .
[42] T. Seemungal,et al. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease , 2001, Thorax.
[43] D. Proud,et al. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. , 1995, The Journal of clinical investigation.
[44] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[45] S. Ishizuka,et al. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. , 2002, American journal of respiratory and critical care medicine.
[46] T. Seemungal,et al. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease , 2000, The European respiratory journal.
[47] L. Davies,et al. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.
[48] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[49] Joan Wilson,et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[50] D. Strachan,et al. Health effects of an air pollution episode in London, December 1991. , 1995, Thorax.
[51] D. Niewoehner,et al. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. , 1987, Annals of internal medicine.
[52] T. Seemungal,et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.
[53] P. Jones,et al. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. , 1995, American journal of respiratory and critical care medicine.
[54] J. Stradling,et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. , 1987, The American journal of medicine.
[55] R. Stockley,et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.